• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

In multicellular organisms, https://stemcellscosts.com/ stem cells are undifferentiated or partially differentiated cells that may change into various sorts of cells and proliferate indefinitely to supply more of the identical stem cell. They're the earliest sort of cell in a cell lineage.[1] They're found in both embryonic and grownup organisms, but they have barely completely different properties in every. They're usually distinguished from progenitor cells, which can not divide indefinitely, and precursor or blast cells, that are often dedicated to differentiating into one cell kind.

In mammals, roughly 50 to 150 cells make up the interior cell mass through the blastocyst stage of embryonic development, around days 5-14. These have stem-cell capability. In vivo, they ultimately differentiate into all of the body's cell sorts (making them pluripotent). This process starts with the differentiation into the three germ layers - the ectoderm, mesoderm and endoderm - on the gastrulation stage. However, when they're isolated and cultured in vitro, they are often kept in the stem-cell stage and are referred to as embryonic stem cells (ESCs).

Adult stem cells are found in a number of select areas in the physique, known as niches, reminiscent of these in the bone marrow or gonads. They exist to replenish rapidly misplaced cell varieties and are multipotent or unipotent, meaning they solely differentiate into a few cell sorts or one sort of cell. In mammals, they embrace, among others, hematopoietic stem cells, which replenish blood and immune cells, basal cells, which maintain the skin epithelium, and mesenchymal stem cells, which maintain bone, cartilage, muscle and fats cells. Adult stem cells are a small minority of cells; they are vastly outnumbered by the progenitor cells and terminally differentiated cells that they differentiate into.[1]

Research into stem cells grew out of findings by Canadian biologists Ernest McCulloch, James Till and Andrew J. Becker at the University of Toronto and the Ontario Cancer Institute within the 1960s.[2][3] As of 2016[update], the only established medical therapy utilizing stem cells is hematopoietic stem cell transplantation,[4] first performed in 1958 by French oncologist Georges Mathé. Since 1998 nonetheless, it has been possible to tradition and differentiate human embryonic stem cells (in stem-cell lines). The means of isolating these cells has been controversial, because it usually results in the destruction of the embryo. Sources for isolating ESCs have been restricted in some European countries and Canada, but others such as the UK and China have promoted the research.[5] Somatic cell nuclear transfer is a cloning methodology that can be utilized to create a cloned embryo for using its embryonic stem cells in stem cell therapy.[6] In 2006, a Japanese crew led by Shinya Yamanaka found a technique to transform mature body cells again into stem cells. These had been termed induced pluripotent stem cells (iPSCs).[7]

History

The time period stem cell was coined by Theodor Boveri and Valentin Haecker in late 19th century.[8] Pioneering works in principle of blood stem cell were performed to start with of twentieth century by Artur Pappenheim, Alexander Maximow, Franz Ernst Christian Neumann.[8]

The important thing properties of a stem cell have been first outlined by Ernest McCulloch and James Till at the University of Toronto and the Ontario Cancer Institute within the early 1960s. They found the blood-forming stem cell, the hematopoietic stem cell (HSC), by means of their pioneering work in mice. McCulloch and Till began a sequence of experiments during which bone marrow cells had been injected into irradiated mice. They noticed lumps within the spleens of the mice that had been linearly proportional to the variety of bone marrow cells injected. They hypothesized that each lump (colony) was a clone arising from a single marrow cell (stem cell). In subsequent work, McCulloch and Till, joined by graduate pupil Andrew John Becker and senior scientist Louis Siminovitch, confirmed that every lump did in actual fact come up from a single cell. Their results were published in Nature in 1963. In that same 12 months, Siminovitch was a lead investigator for research that discovered colony-forming cells were able to self-renewal, which is a key defining property of stem cells that Till and McCulloch had theorized.[9]

The first therapy utilizing stem cells was a bone marrow transplant carried out by French oncologist Georges Mathé in 1956 on 5 workers at the Vinča Nuclear Institute in Yugoslavia who had been affected by a criticality accident. The staff all survived.[10]

In 1981, embryonic stem (ES) cells had been first remoted and successfully cultured using mouse blastocysts by British biologists Martin Evans and Matthew Kaufman. This allowed the formation of murine genetic models, a system through which the genes of mice are deleted or altered in order to study their function in pathology. In 1991, a process that allowed the human stem cell to be remoted was patented by Ann Tsukamoto. By 1998, human embryonic stem cells were first remoted by American biologist James Thomson, which made it potential to have new transplantation methods or varied cell varieties for testing new remedies. In 2006, Shinya Yamanaka's workforce in Kyoto, Japan transformed fibroblasts into pluripotent stem cells by modifying the expression of only four genes. The feat represents the origin of induced pluripotent stem cells, referred to as iPS cells.[7]

In 2011, a feminine maned wolf, run over by a truck, underwent stem cell treatment on the Zoo Brasília, this being the primary recorded case of the usage of stem cells to heal injuries in a wild animal.[11][12]

Properties

The classical definition of a stem cell requires that it possesses two properties:

- Self-renewal: the ability to undergo quite a few cycles of cell growth and cell division, referred to as cell proliferation, whereas sustaining the undifferentiated state.Potency: the capacity to differentiate into specialized cell varieties. In the strictest sense, this requires stem cells to be both totipotent or pluripotent-to be ready to offer rise to any mature cell type, although multipotent or unipotent progenitor cells are sometimes known as stem cells. Aside from this, it is claimed that stem cell function is regulated in a feedback mechanism.
Self-renewal

Two mechanisms ensure that a stem cell inhabitants is maintained (does not shrink in size):

1. Asymmetric cell division: a stem cell divides into one mother cell, which is equivalent to the original stem cell, and another daughter cell, which is differentiated.

When a stem cell self-renews, it divides and disrupts the undifferentiated state. This self-renewal demands management of cell cycle as well as upkeep of multipotency or pluripotency, which all is dependent upon the stem cell.[13]

H.

Stem cells use telomerase, a protein that restores telomeres, to protect their DNA and extend their cell division restrict (the Hayflick limit).[14]

Potency meaning

Potency specifies the differentiation potential (the potential to differentiate into totally different cell sorts) of the stem cell.[15]

Totipotent (also referred to as omnipotent) stem cells can differentiate into embryonic and extraembryonic cell sorts. Such cells can construct a whole, viable organism.[15] These cells are produced from the fusion of an egg and sperm cell. Cells produced by the primary few divisions of the fertilized egg are also totipotent.[16]Pluripotent stem cells are the descendants of totipotent cells and may differentiate into practically all cells,[15] i.e. cells derived from any of the three germ layers.[17]Multipotent stem cells can differentiate into numerous cell varieties, but only these of a carefully associated household of cells.[15]Oligopotent stem cells can differentiate into only some cell types, reminiscent of lymphoid or myeloid stem cells.[15]Unipotent cells can produce only one cell kind, their own,[15] however have the property of self-renewal, which distinguishes them from non-stem cells
Identification

In follow, stem cells are recognized by whether they will regenerate tissue. For instance, the defining take a look at for bone marrow or hematopoietic stem cells (HSCs) is the power to transplant the cells and save a person with out HSCs. This demonstrates that the cells can produce new blood cells over a long run. It should even be possible to isolate stem cells from the transplanted individual, which can themselves be transplanted into another particular person without HSCs, demonstrating that the stem cell was capable of self-renew.

Properties of stem cells might be illustrated in vitro, utilizing methods reminiscent of clonogenic assays, during which single cells are assessed for their capacity to differentiate and self-renew.[18][19] Stem cells will also be isolated by their possession of a particular set of cell surface markers. However, in vitro culture conditions can alter the behavior of cells, making it unclear whether or not the cells shall behave in an analogous manner in vivo. There is considerable debate as to whether or not some proposed grownup cell populations are actually stem cells.[20]

Embryonic

Embryonic stem cells (ESCs) are the cells of the inner cell mass of a blastocyst, formed prior to implantation within the uterus.[21] In human embryonic improvement the blastocyst stage is reached 4-5 days after fertilization, at which time it consists of 50-one hundred fifty cells. ESCs are pluripotent and provides rise throughout improvement to all derivatives of the three germ layers: ectoderm, endoderm and mesoderm. In other phrases, they'll grow to be each of the more than 200 cell types of the grownup body when given adequate and obligatory stimulation for a selected cell type. They don't contribute to the extraembryonic membranes or to the placenta.

During embryonic improvement the cells of the internal cell mass constantly divide and develop into more specialised. For instance, a portion of the ectoderm in the dorsal part of the embryo specializes as 'neurectoderm', which can grow to be the future central nervous system (CNS).[22] Later in development, neurulation causes the neurectoderm to form the neural tube. At the neural tube stage, the anterior portion undergoes encephalization to generate or 'sample' the essential type of the mind. At this stage of development, the principal cell sort of the CNS is taken into account a neural stem cell.

The neural stem cells self-renew and in some unspecified time in the future transition into radial glial progenitor cells (RGPs). Early-formed RGPs self-renew by symmetrical division to type a reservoir group of progenitor cells. These cells transition to a neurogenic state and start to divide asymmetrically to provide a large range of many different neuron sorts, each with unique gene expression, morphological, and practical traits. The technique of producing neurons from radial glial cells is named neurogenesis. The radial glial cell, has a particular bipolar morphology with extremely elongated processes spanning the thickness of the neural tube wall. It shares some glial traits, most notably the expression of glial fibrillary acidic protein (GFAP).[23][24] The radial glial cell is the first neural stem cell of the developing vertebrate CNS, and its cell physique resides within the ventricular zone, adjoining to the growing ventricular system. Neural stem cells are dedicated to the neuronal lineages (neurons, astrocytes, and oligodendrocytes), and thus their potency is restricted.[22]

Nearly all research so far has made use of mouse embryonic stem cells (mES) or human embryonic stem cells (hES) derived from the early internal cell mass. Both have the essential stem cell traits, but they require very completely different environments in order to take care of an undifferentiated state. Mouse ES cells are grown on a layer of gelatin as an extracellular matrix (for assist) and require the presence of leukemia inhibitory factor (LIF) in serum media. A drug cocktail containing inhibitors to GSK3B and the MAPK/ERK pathway, referred to as 2i, has additionally been proven to maintain pluripotency in stem cell culture.[25] Human ESCs are grown on a feeder layer of mouse embryonic fibroblasts and require the presence of primary fibroblast progress factor (bFGF or FGF-2).[26] Without optimal culture circumstances or genetic manipulation,[27] embryonic stem cells will quickly differentiate.

A human embryonic stem cell can be outlined by the expression of a number of transcription factors and cell surface proteins. The transcription components Oct-4, Nanog, and Sox2 form the core regulatory community that ensures the suppression of genes that result in differentiation and the maintenance of pluripotency.[28] The cell surface antigens mostly used to establish hES cells are the glycolipids stage particular embryonic antigen three and 4, and the keratan sulfate antigens Tra-1-60 and Tra-1-81. The molecular definition of a stem cell includes many extra proteins and continues to be a topic of research.[29]

By using human embryonic stem cells to produce specialized cells like nerve cells or coronary heart cells in the lab, scientists can acquire access to grownup human cells without taking tissue from patients. They'll then study these specialized grownup cells intimately to try to discern complications of diseases, or to check cell reactions to proposed new medicine.

Because of their combined skills of limitless growth and pluripotency, embryonic stem cells stay a theoretically potential supply for regenerative drugs and tissue substitute after damage or illness.,[30] nevertheless, there are at present no permitted remedies utilizing ES cells. The first human trial was accredited by the US Food and Drug Administration in January 2009.[31] However, the human trial was not initiated until October 13, 2010 in Atlanta for spinal cord damage research. On November 14, 2011 the corporate conducting the trial (Geron Corporation) introduced that it will discontinue further growth of its stem cell applications.[32] Differentiating ES cells into usable cells while avoiding transplant rejection are only a few of the hurdles that embryonic stem cell researchers still face.[33] Embryonic stem cells, being pluripotent, require specific indicators for appropriate differentiation - if injected straight into another physique, ES cells will differentiate into many different types of cells, causing a teratoma. Ethical concerns regarding the use of unborn human tissue are another purpose for the lack of authorised remedies using embryonic stem cells. Many nations at the moment have moratoria or limitations on either human ES cell research or the production of new human ES cell lines.

- Mouse embryonic stem cells with fluorescent marker

- Human embryonic stem cell colony on mouse embryonic fibroblast feeder layer

Mesenchymal stem cells

Mesenchymal stem cells (MSC) or mesenchymal stromal cells, also known as medicinal signaling cells are identified to be multipotent, which can be found in grownup tissues, for example, within the muscle, liver, bone marrow and adipose tissue. Mesenchymal stem cells often function as structural assist in numerous organs as talked about above, and management the movement of substances. MSC can differentiate into numerous cell categories as an illustration of adipocytes, osteocytes, and chondrocytes, derived by the mesodermal layer.[34] Where the mesoderm layer provides an increase to the body's skeletal components, reminiscent of regarding the cartilage or bone. The term "meso" means middle, infusion originated from the Greek, signifying that mesenchymal cells are capable of range and journey in early embryonic development among the ectodermal and endodermal layers. This mechanism helps with house-filling thus, key for repairing wounds in adult organisms that must do with mesenchymal cells in the dermis (pores and skin), bone, or muscle.[35]

Mesenchymal stem cells are recognized to be important for regenerative medication. They are broadly studied in clinical trials. Since they're simply remoted and acquire high yield, excessive plasticity, which makes able to facilitate inflammation and encourage cell growth, cell differentiation, and restoring tissue derived from immunomodulation and immunosuppression. MSC comes from the bone marrow, which requires an aggressive process on the subject of isolating the quantity and high quality of the remoted cell, and it varies by how old the donor. When comparing the charges of MSC in the bone marrow aspirates and bone marrow stroma, the aspirates are likely to have decrease charges of MSC than the stroma. MSC are known to be heterogeneous, and so they express a excessive stage of pluripotent markers when compared to different forms of stem cells, similar to embryonic stem cells.[34] MSCs injection results in wound healing primarily by stimulation of angiogenesis.[36]

Embryonic stem cells (ESCs) have the flexibility to divide indefinitely whereas maintaining their pluripotency, which is made potential via specialized mechanisms of cell cycle management.[37] In comparison with proliferating somatic cells, ESCs have distinctive cell cycle traits-akin to fast cell division brought on by shortened G1 phase, absent G0 section, and modifications in cell cycle checkpoints-which leaves the cells largely in S section at any given time.[37][38] ESCs' speedy division is demonstrated by their brief doubling time, which ranges from 8 to 10 hours, whereas somatic cells have doubling time of approximately 20 hours or longer.[39] As cells differentiate, these properties change: G1 and G2 phases lengthen, resulting in longer cell division cycles. This suggests that a selected cell cycle construction could contribute to the institution of pluripotency.[37]

Particularly as a result of G1 phase is the part during which cells have elevated sensitivity to differentiation, shortened G1 is one of the important thing characteristics of ESCs and plays an essential function in sustaining undifferentiated phenotype. Although the exact molecular mechanism remains solely partially understood, several research have proven insight on how ESCs progress by G1-and potentially different phases-so quickly.[38]

The cell cycle is regulated by advanced community of cyclins, cyclin-dependent kinases (Cdk), cyclin-dependent kinase inhibitors (Cdkn), pocket proteins of the retinoblastoma (Rb) household, and other accessory elements.[39] Foundational perception into the distinctive regulation of ESC cell cycle was gained by research on mouse ESCs (mESCs).[38] mESCs showed a cell cycle with extremely abbreviated G1 section, which enabled cells to rapidly alternate between M part and S section. In a somatic cell cycle, oscillatory exercise of Cyclin-Cdk complexes is observed in sequential action, which controls essential regulators of the cell cycle to induce unidirectional transitions between phases: Cyclin D and Cdk4/6 are energetic in the G1 part, whereas Cyclin E and Cdk2 are energetic during the late G1 phase and S section; and Cyclin A and Cdk2 are lively within the S part and G2, whereas Cyclin B and Cdk1 are energetic in G2 and M section.[39] However, in mESCs, this typically ordered and oscillatory activity of Cyclin-Cdk complexes is absent. Rather, the Cyclin E/Cdk2 advanced is constitutively energetic throughout the cycle, maintaining retinoblastoma protein (pRb) hyperphosphorylated and thus inactive. This permits for direct transition from M phase to the late G1 phase, resulting in absence of D-sort cyclins and due to this fact a shortened G1 section.[38] Cdk2 activity is crucial for both cell cycle regulation and cell-destiny selections in mESCs; downregulation of Cdk2 exercise prolongs G1 part development, establishes a somatic cell-like cell cycle, and induces expression of differentiation markers.[40]

In human ESCs (hESCs), the duration of G1 is dramatically shortened. This has been attributed to excessive mRNA ranges of G1-associated Cyclin D2 and Cdk4 genes and low levels of cell cycle regulatory proteins that inhibit cell cycle development at G1, corresponding to p21CipP1, p27Kip1, and p57Kip2.[37][41] Furthermore, regulators of Cdk4 and Cdk6 activity, resembling members of the Ink family of inhibitors (p15, p16, p18, and p19), are expressed at low ranges or not in any respect. Thus, much like mESCs, hESCs show excessive Cdk exercise, with Cdk2 exhibiting the best kinase exercise. Also just like mESCs, hESCs show the importance of Cdk2 in G1 section regulation by exhibiting that G1 to S transition is delayed when Cdk2 exercise is inhibited and G1 is arrest when Cdk2 is knocked down.[37] However not like mESCs, hESCs have a purposeful G1 section. hESCs present that the actions of Cyclin E/Cdk2 and Cyclin A/Cdk2 complexes are cell cycle-dependent and the Rb checkpoint in G1 is practical.[39]

ESCs are additionally characterized by G1 checkpoint non-performance, regardless that the G1 checkpoint is crucial for sustaining genomic stability. In response to DNA damage, ESCs do not stop in G1 to repair DNA damages but as a substitute, rely upon S and G2/M checkpoints or undergo apoptosis. The absence of G1 checkpoint in ESCs permits for the removing of cells with broken DNA, therefore avoiding potential mutations from inaccurate DNA restore.[37] In line with this concept, ESCs are hypersensitive to DNA injury to attenuate mutations handed onto the next technology.[39]

Fetal

The primitive stem cells positioned within the organs of fetuses are referred to as fetal stem cells.[42]

There are two types of fetal stem cells:

1. Fetal proper stem cells come from the tissue of the fetus proper and are typically obtained after an abortion. These stem cells aren't immortal however have a high level of division and are multipotent.2. Extraembryonic fetal stem cells come from extraembryonic membranes, and are usually not distinguished from adult stem cells. These stem cells are acquired after delivery, they are not immortal however have a high stage of cell division, and are pluripotent.[43]
Adult

Adult stem cells, additionally known as somatic (from Greek σωματικóς, "of the physique") stem cells, are stem cells which maintain and repair the tissue by which they are discovered.[44]

There are three recognized accessible sources of autologous grownup stem cells in people:

Bone marrow, which requires extraction by harvesting, normally from pelvic bones via surgery.[45]1. Adipose tissue (fats cells), which requires extraction by liposuction.[46]2. Blood, which requires extraction by means of apheresis, wherein blood is drawn from the donor (much like a blood donation), and passed via a machine that extracts the stem cells and returns other parts of the blood to the donor.[47]
Stem cells will also be taken from umbilical cord blood just after birth. Of all stem cell sorts, autologous harvesting entails the least threat. By definition, autologous cells are obtained from one's personal physique, simply as one might financial institution their very own blood for elective surgical procedures.[citation wanted]

Pluripotent grownup stem cells are rare and usually small in quantity, however they are often found in umbilical cord blood and different tissues.[48] Bone marrow is a rich supply of adult stem cells,[49] which have been utilized in treating several circumstances including liver cirrhosis,[50] chronic limb ischemia[51] and endstage heart failure.[52] The amount of bone marrow stem cells declines with age and is higher in males than females during reproductive years.[53] Much adult stem cell research to date has aimed to characterize their potency and self-renewal capabilities.[54] DNA injury accumulates with age in both stem cells and the cells that comprise the stem cell atmosphere. This accumulation is taken into account to be responsible, no less than partly, for growing stem cell dysfunction with aging (see DNA damage principle of aging).[55]

Most adult stem cells are lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal stem cell, adipose-derived stem cell, endothelial stem cell, dental pulp stem cell, and many others.).[56][57] Muse cells (multi-lineage differentiating stress enduring cells) are a just lately found pluripotent stem cell type present in multiple grownup tissues, including adipose, dermal fibroblasts, and bone marrow. While rare, muse cells are identifiable by their expression of SSEA-3, a marker for undifferentiated stem cells, and basic mesenchymal stem cells markers corresponding to CD90, CD105. When subjected to single cell suspension culture, the cells will generate clusters which might be much like embryoid our bodies in morphology in addition to gene expression, together with canonical pluripotency markers Oct4, Sox2, and Nanog.[58]

Adult stem cell therapies have been successfully used for many years to treat leukemia and related bone/blood cancers by means of bone marrow transplants.[59] Adult stem cells are also utilized in veterinary drugs to treat tendon and ligament injuries in horses.[60]

The usage of grownup stem cells in research and therapy isn't as controversial as using embryonic stem cells, as a result of the production of grownup stem cells does not require the destruction of an embryo. Additionally, in cases where adult stem cells are obtained from the supposed recipient (an autograft), the risk of rejection is actually non-existent. Consequently, more US authorities funding is being offered for adult stem cell research.[61]

With the rising demand of human adult stem cells for both research and clinical purposes (typically 1-5 million cells per kg of body weight are required per treatment) it becomes of utmost importance to bridge the gap between the necessity to broaden the cells in vitro and the capability of harnessing the components underlying replicative senescence. Adult stem cells are known to have a restricted lifespan in vitro and to enter replicative senescence almost undetectably upon starting in vitro culturing.[62]

Hematopoietic stem cells

Hematopoietic stem cells (HSCs) are vulnerable to DNA injury and mutations that increase with age.[63] This vulnerability could clarify the elevated threat of gradual rising blood cancers (myeloid malignancies) within the elderly.[63] Several components seem to affect HSC aging together with responses to the manufacturing of reactive oxygen species that will cause DNA harm and genetic mutations as well as altered epigenetic profiling.[64]

Amniotic

Also referred to as perinatal stem cells, these multipotent stem cells are present in amniotic fluid and umbilical cord blood. These stem cells are very active, broaden extensively with out feeders and will not be tumorigenic. Amniotic stem cells are multipotent and can differentiate in cells of adipogenic, osteogenic, myogenic, endothelial, hepatic and in addition neuronal traces.[65] Amniotic stem cells are a topic of energetic research.

Use of stem cells from amniotic fluid overcomes the ethical objections to utilizing human embryos as a source of cells. Roman Catholic teaching forbids the use of embryonic stem cells in experimentation; accordingly, the Vatican newspaper "Osservatore Romano" known as amniotic stem cells "the way forward for medication".[66]

It is feasible to collect amniotic stem cells for donors or for autologous use: the first US amniotic stem cells financial institution[67][68] was opened in 2009 in Medford, MA, by Biocell Center Corporation[69][70][71] and collaborates with varied hospitals and universities all around the world.[72]

Induced pluripotent

Adult stem cells have limitations with their potency; not like embryonic stem cells (ESCs), they aren't able to differentiate into cells from all three germ layers. As such, they're deemed multipotent.

However, reprogramming allows for the creation of pluripotent cells, induced pluripotent stem cells (iPSCs), from adult cells. These will not be adult stem cells, however somatic cells (e.g. epithelial cells) reprogrammed to provide rise to cells with pluripotent capabilities. Using genetic reprogramming with protein transcription factors, pluripotent stem cells with ESC-like capabilities have been derived.[73][74][75] The first demonstration of induced pluripotent stem cells was conducted by Shinya Yamanaka and his colleagues at Kyoto University.[76] They used the transcription elements Oct3/4, Sox2, c-Myc, and Klf4 to reprogram mouse fibroblast cells into pluripotent cells.[73][77] Subsequent work used these factors to induce pluripotency in human fibroblast cells.[78] Junying Yu, James Thomson, and their colleagues on the University of Wisconsin-Madison used a different set of factors, Oct4, Sox2, Nanog and Lin28, and carried out their experiments utilizing cells from human foreskin.[73][79] However, they were in a position to replicate Yamanaka's discovering that inducing pluripotency in human cells was attainable.

Induced pluripotent stem cells differ from embryonic stem cells. They share many similar properties, similar to pluripotency and differentiation potential, the expression of pluripotency genes, epigenetic patterns, embryoid physique and teratoma formation, and viable chimera formation,[76][77] but there are various differences within these properties. The chromatin of iPSCs appears to be extra "closed" or methylated than that of ESCs.[76][77] Similarly, the gene expression sample between ESCs and iPSCs, and even iPSCs sourced from totally different origins.[76] There are thus questions in regards to the "completeness" of reprogramming and the somatic reminiscence of induced pluripotent stem cells. Despite this, inducing somatic cells to be pluripotent seems to be viable.

Because of the success of those experiments, Ian Wilmut, who helped create the primary cloned animal Dolly the Sheep, has announced that he will abandon somatic cell nuclear transfer as an avenue of research.[80]

The flexibility to induce pluripotency advantages developments in tissue engineering. By offering a suitable scaffold and microenvironment, iPSC might be differentiated into cells of therapeutic utility, and for in vitro models to study toxins and pathogenesis.[81]

Induced pluripotent stem cells present a number of therapeutic advantages. Like ESCs, they are pluripotent. They thus have nice differentiation potential; theoretically, they could produce any cell throughout the human body (if reprogramming to pluripotency was "complete").[76] Moreover, not like ESCs, they potentially may allow medical doctors to create a pluripotent stem cell line for each individual affected person.[82] Frozen blood samples can be utilized as a worthwhile supply of induced pluripotent stem cells.[83] Patient particular stem cells permit for the screening for unwanted effects earlier than drug remedy, as effectively as the reduced threat of transplantation rejection.[82] Despite their present limited use therapeutically, iPSCs hold great potential for future use in medical treatment and research.

Cell cycle management

The important thing factors controlling the cell cycle additionally regulate pluripotency. Thus, manipulation of relevant genes can maintain pluripotency and reprogram somatic cells to an induced pluripotent state.[39] However, reprogramming of somatic cells is commonly low in effectivity and regarded stochastic.[84]

With the concept a more fast cell cycle is a key part of pluripotency, reprogramming effectivity might be improved. Methods for enhancing pluripotency by manipulation of cell cycle regulators embrace: overexpression of Cyclin D/Cdk4, phosphorylation of Sox2 at S39 and S253, overexpression of Cyclin A and Cyclin E, knockdown of Rb, and knockdown of members of the Cip/Kip household or the Ink family.[39] Furthermore, reprogramming efficiency is correlated with the variety of cell divisions happened through the stochastic section, which is suggested by the growing inefficiency of reprogramming of older or sluggish diving cells.[85]

Lineage

Lineage is a crucial process to investigate developing embryos. Since cell lineages reveals the relationship between cells at every division. This helps in analyzing stem cell lineages along the best way which helps recognize stem cell effectiveness, lifespan, and different elements. With the technique of cell lineage mutant genes may be analyzed in stem cell clones that can assist in genetic pathways. These pathways can regulate how the stem cell perform.[86]

To make sure self-renewal, stem cells undergo two forms of cell division (see Stem cell division and differentiation diagram). Symmetric division offers rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division, then again, produces just one stem cell and a progenitor cell with restricted self-renewal potential. Progenitors can undergo a number of rounds of cell division before terminally differentiating right into a mature cell. It is feasible that the molecular distinction between symmetric and asymmetric divisions lies in differential segregation of cell membrane proteins (similar to receptors) between the daughter cells.[87]

An alternative idea is that stem cells remain undifferentiated because of environmental cues of their explicit niche. Stem cells differentiate when they go away that niche or not obtain these alerts. Studies in Drosophila germarium have recognized the alerts decapentaplegic and adherens junctions that forestall germarium stem cells from differentiating.[88][89]

Within the United States, Executive Order 13505 established that federal cash can be used for research wherein authorised human embryonic stem-cell (hESC) strains are used, but it cannot be used to derive new traces.[90] The National Institutes of Health (NIH) Guidelines on Human Stem Cell Research, efficient July 7, 2009, applied the Executive Order 13505 by establishing standards which hESC lines should meet to be accredited for funding.[91] The NIH Human Embryonic Stem Cell Registry can be accessed on-line and has updated info on cell strains eligible for NIH funding.[92] There are 486 authorised lines as of January 2022.[93]

Therapies

Stem cell therapy is using stem cells to deal with or forestall a disease or situation. Bone marrow transplant is a type of stem cell therapy that has been used for a few years as a result of it has confirmed to be effective in clinical trials.[94][95] Stem cell implantation may assist in strengthening the left-ventricle of the guts, as well as retaining the guts tissue to patients who have suffered from heart assaults in the past.[96]

For over ninety years, hematopoietic stem cell transplantation (HSCT) has been used to treat individuals with situations similar to leukaemia and lymphoma; this is the one broadly practiced type of stem-cell therapy.[94][97][98] As of 2016[update], the one established therapy using stem cells is hematopoietic stem cell transplantation.[99] This usually takes the form of a bone-marrow transplantation, however the cells may also be derived from umbilical cord blood. Research is underway to develop varied sources for stem cells as well as to apply stem-cell therapies for neurodegenerative diseases[100][101][102] and situations resembling diabetes and heart disease.

Advantages

Stem cell therapies might lower signs of the illness or situation that is being handled. The lowering of symptoms may enable patients to reduce the drug intake of the illness or situation. Stem cell treatment can also provide data for society to additional stem cell understanding and future treatments.[103] The physicians' creed could be to do no damage, and stem cells make that less complicated than ever before. Surgical processes by their character are dangerous. Tissue has to be dropped as a method to achieve a profitable outcome. One may stop the dangers of surgical interventions utilizing stem cells. Additionally, there's a possibility of illness, and whether the process fails, additional surgical procedure could also be required. Risks related to anesthesia can also be eradicated with stem cells.[104] On top of that, stem cells have been harvested from the patient's body and redeployed during which they're wished. Since they come from the affected person's own physique, this is known as an autologous remedy. Autologous treatments are thought to be the safest as a result of there's probably zero probability of donor substance rejection.

Disadvantages

Stem cell treatments might require immunosuppression due to a requirement for radiation before the transplant to remove the person's previous cells, or because the patient's immune system may goal the stem cells. One approach to avoid the second chance is to make use of stem cells from the same patient who's being handled.

Pluripotency in sure stem cells could also make it tough to acquire a selected cell type. It is usually troublesome to acquire the exact cell sort wanted, as a result of not all cells in a population differentiate uniformly. Undifferentiated cells can create tissues other than desired varieties.[105]

Some stem cells kind tumors after transplantation;[106] pluripotency is linked to tumor formation particularly in embryonic stem cells, fetal proper stem cells, induced pluripotent stem cells. Fetal proper stem cells form tumors despite multipotency.[107]

Ethical considerations are additionally raised about the observe of using or researching embryonic stem cells. Harvesting cells from the blastocyst results in the death of the blastocyst. The concern is whether or not the blastocyst ought to be thought-about as a human life.[108] The talk on this challenge is mainly a philosophical one, not a scientific one.

Stem cell tourism

Stem cell tourism is the part of the medical tourism business by which patients journey to obtain stem cell procedures.[109]

The United States has had an explosion of "stem cell clinics".[110] Stem cell procedures are highly profitable for clinics. The promoting sounds authoritative but the efficacy and security of the procedures is unproven. Patients generally expertise complications, similar to spinal tumors[111] and loss of life. The excessive expense can also result in monetary issues.[111] Based on researchers, there is a need to educate the public, patients, and docs about this concern.[112]

In line with the International Society for Stem Cell Research, the most important academic group that advocates for stem cell research, stem cell therapies are beneath improvement and cannot yet be said to be proven.[113][114] Doctors ought to inform patients that clinical trials continue to research whether or not these therapies are safe and efficient but that unethical clinics current them as confirmed.[115]

Research

A few of the basic patents masking human embryonic stem cells are owned by the Wisconsin Alumni Research Foundation (WARF) - they are patents 5,843,780, 6,200,806, and 7,029,913 invented by James A. Thomson. WARF doesn't implement these patents towards educational scientists, but does implement them towards firms.[116]

In 2006, a request for the US Patent and Trademark Office (USPTO) to re-study the three patents was filed by the public Patent Foundation on behalf of its client, the non-profit patent-watchdog group Consumer Watchdog (formerly the inspiration for Taxpayer and Consumer Rights).[116] In the re-examination course of, which involves several rounds of dialogue between the USPTO and the events, the USPTO initially agreed with Consumer Watchdog and rejected all of the claims in all three patents,[117] nonetheless in response, WARF amended the claims of all three patents to make them extra narrow, and in 2008 the USPTO found the amended claims in all three patents to be patentable. The decision on one of the patents (7,029,913) was appealable, while the selections on the opposite two were not.[118][119] Consumer Watchdog appealed the granting of the '913 patent to the USPTO's Board of Patent Appeals and Interferences (BPAI) which granted the enchantment, and in 2010 the BPAI determined that the amended claims of the '913 patent weren't patentable.[120] However, WARF was able to re-open prosecution of the case and did so, amending the claims of the '913 patent once more to make them more slender, and in January 2013 the amended claims have been allowed.[121]

In July 2013, Consumer Watchdog introduced that it could attraction the choice to permit the claims of the '913 patent to the US Court of Appeals for the Federal Circuit (CAFC), the federal appeals court docket that hears patent instances.[122] At a hearing in December 2013, the CAFC raised the query of whether or not Consumer Watchdog had legal standing to appeal; the case couldn't proceed until that difficulty was resolved.[123]

Investigations

Diseases and circumstances where stem cell treatment is being investigated embrace:

Diabetes[124]Androgenic Alopecia and hair loss[125][126]Rheumatoid arthritis[124]Parkinson's illness[124]Alzheimer's illness[124]Respiratory illness[127]Osteoarthritis[124]Stroke and traumatic mind injury repair[128]Learning incapacity as a result of congenital disorder[129]Spinal cord damage restore[130]Heart infarction[131]- Anti-cancer therapies[128]Baldness reversal[132]- Replace lacking teeth[133]- Repair hearing[134]- Restore imaginative and prescient[135] and restore damage to the cornea[136]Amyotrophic lateral sclerosis[137]Crohn's disease[138]Wound healing[139]Male infertility on account of absence of spermatogonial stem cells.[140] In current studies, scientists have found a means to resolve this drawback by reprogramming a cell and turning it right into a spermatozoon. Other research have confirmed the restoration of spermatogenesis by introducing human iPSC cells in mice testicles. This could imply the tip of azoospermia.[141]Female infertility: oocytes made from embryonic stem cells. Scientists have found the ovarian stem cells, a rare sort of cells (0.014%) discovered in the ovary. They may very well be used as a treatment not just for infertility, but also for premature ovarian insufficiency (POI).[142] New analysis posted in Science Direct means that ovarian follicles may very well be triggered to develop in the ovarian setting by using stem cells present in bone marrow. This examine was performed by infusing human bone marrow stem cells into immune-deficient mice to imrpove fertilization.[143] Another study conducted using mice with damanged ovarian function from chemothearpy discovered that in vivo thearpy with bone marrow stem cells can heal the damaged ovaries. [144] Both of these studies are proof-of-idea and should be furthered examined, however they have the likelihood improve fertility for individuals who've POI from chemothearpy treatment.- Critical Limb Ischemia[145]
Research is underway to develop various sources for stem cells, and to use stem cell therapies for neurodegenerative diseases and situations, diabetes, heart disease, and other circumstances.[146] Research is also underway in generating organoids using stem cells, which would allow for additional understanding of human improvement, organogenesis, and modeling of human diseases.[147]

In newer years, with the flexibility of scientists to isolate and culture embryonic stem cells, and with scientists' growing potential to create stem cells utilizing somatic cell nuclear switch and techniques to create induced pluripotent stem cells, controversy has crept in, each associated to abortion politics and to human cloning.

Hepatotoxicity and drug-induced liver injury account for a substantial number of failures of latest medicine in growth and market withdrawal, highlighting the need for screening assays equivalent to stem cell-derived hepatocyte-like cells, which can be able to detecting toxicity early in the drug improvement process.[148]

Notable research

In August 2021, researchers within the Princess Margaret Cancer Centre at the University Health Network printed their discovery of a dormancy mechanism in key stem cells which may assist develop cancer therapies in the future.[149]

Cell bankHuman genomeMeristemMesenchymal stem cellOvarian stem cellPartial cloningPlant stem cellStem cell controversyStem cell markerStem cell laws and policy in Iran
References

^ a b Atala A, Lanza R (2012). Handbook of Stem Cells. Academic Press. p. 452. ISBN 978-0-12-385943-3.^ Becker AJ, McCulloch EA, Till JE (February 1963). "Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells". Nature. 197 (4866): 452-454. Bibcode:1963Natur.197..452B. doi:10.1038/197452a0. hdl:1807/2779. ISSN 0028-0836. PMID 13970094. S2CID 11106827.^ Siminovitch L, McCulloch EA, Till JE (December 1963). "The distribution of colony-forming cells amongst spleen colonies". Journal of Cellular and Comparative Physiology. 62 (3): 327-336. doi:10.1002/jcp.1030620313. hdl:1807/2778. PMID 14086156. S2CID 43875977.^ Müller AM, Huppertz S, Henschler R (July 2016). "Hematopoietic Stem Cells in Regenerative Medicine: Astray or on the trail?". Transfusion Medicine and Hemotherapy. Forty three (4): 247-254. doi:10.1159/000447748. PMC 5040947. PMID 27721700.^ Ralston, Michelle (17 July 2008). "Stem Cell Research World wide". Pew Research Center's Religion & Public Life Project.^ Tuch, B. E. (September 2006). "Stem cells: a clinical update". Australian Family Physician. 35 (9): 719-721. PMID 16969445. ProQuest 216301343.^ a b Ferreira L (2014-01-03). "Stem Cells: A brief History and Outlook". Stem Cells: A quick History and Outlook - Science in the News. WordPress. Retrieved 3 December 2019.^ a b Ramalho-Santos, Miguel; Willenbring, Holger (June 2007). "On the Origin of the Term 'Stem Cell'". Cell Stem Cell. 1 (1): 35-38. doi:10.1016/j.stem.2007.05.013. PMID 18371332.^ MacPherson C. "The Accidental Discovery of Stem Cells". USask News. University of Saskatchewan. Retrieved 3 December 2019.^ Vinca reactor accident, 1958 Archived 27 January 2011 on the Wayback Machine, compiled by Wm. Robert Johnston^ Boyle, Rebecca. Injured Brazilian Wolf Is First Wild Animal Treated With Stem Cells. Popular Science, January 15, 2011. Retrieved 2021-08-07.^ Tratamento. Conselho Federal de Medicina Veterinária, 2011-11-01, (Portuguese). Retrieved 2021-08-07.^ Shenghui, H. E., Nakada, D., & Morrison, S. J. (2009). Mechanisms of stem cell self-renewal. Annual Review of Cell and Developmental, 25, 377-406.^ Cong YS, Wright WE, Shay JW (September 2002). "Human telomerase and its regulation". Microbiology and Molecular Biology Reviews. Sixty six (3): 407-425, table of contents. doi:10.1128/MMBR.66.3.407-425.2002. PMC 120798. PMID 12208997.^ a b c d e f Schöler HR (2007). "The Potential of Stem Cells: An inventory". In Nikolaus Knoepffler, Dagmar Schipanski, Stefan Lorenz Sorgner (eds.). Humanbiotechnology as Social Challenge. Ashgate Publishing. p. 28. ISBN 978-0-7546-5755-2.^ Mitalipov S, Wolf D (2009). "Totipotency, pluripotency and nuclear reprogramming". Engineering of Stem Cells. Advances in Biochemical Engineering/Biotechnology. Vol. 114. Springer. pp. 185-199. Bibcode:2009esc..e book..185M. doi:10.1007/10_2008_45. ISBN 978-3-540-88805-5. PMC 2752493. PMID 19343304.^ Ulloa-Montoya F, Verfaillie CM, Hu WS (July 2005). "Culture techniques for pluripotent stem cells". Journal of Bioscience and Bioengineering. A hundred (1): 12-27. doi:10.1263/jbb.100.12. PMID 16233846.^ Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luriá EA, Ruadkow IA (1974). "Precursors for fibroblasts in numerous populations of hematopoietic cells as detected by the in vitro colony assay technique". Experimental Hematology. 2 (2): 83-92. PMID 4455512. INIST PASCAL7536501060 NAID 10025700209.^ Friedenstein AJ, Gorskaja JF, Kulagina NN (September 1976). "Fibroblast precursors in regular and irradiated mouse hematopoietic organs". Experimental Hematology. Four (5): 267-274. PMID 976387.^ Sekhar L, Bisht N (2006-09-01). "Stem Cell Therapy". Apollo Medicine. 3 (3): 271-276. doi:10.1016/S0976-0016(11)60209-3.^ Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (November 1998). "Embryonic stem cell traces derived from human blastocysts". Science. 282 (5391): 1145-1147. Bibcode:1998Sci...282.1145T. doi:10.1126/science.282.5391.1145. PMID 9804556.^ a b Gilbert, Scott F. (2014). Developmental Biology. Sinauer Associates. ISBN 978-0-87893-978-7.[web page needed]^ Rakic P (October 2009). "Evolution of the neocortex: a perspective from developmental biology". Nature Reviews. Neuroscience. 10 (10): 724-735. doi:10.1038/nrn2719. PMC 2913577. PMID 19763105.^ Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR (February 2001). "Neurons derived from radial glial cells set up radial items in neocortex". Nature. 409 (6821): 714-720. Bibcode:2001Natur.409..714N. doi:10.1038/35055553. PMID 11217860. S2CID 3041502.^ Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, Smith A (May 2008). "The ground state of embryonic stem cell self-renewal". Nature. 453 (7194): 519-523. Bibcode:2008Natur.453..519Y. doi:10.1038/nature06968. PMC 5328678. PMID 18497825.^ "Culture of Human Embryonic Stem Cells (hESC)". National Institutes of Health. Archived from the unique on 2010-01-06. Retrieved 2010-03-07.^ Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A (May 2003). "Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells". Cell. 113 (5): 643-655. doi:10.1016/S0092-8674(03)00392-1. hdl:1842/843. PMID 12787505. S2CID 2236779.^ Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA (September 2005). "Core transcriptional regulatory circuitry in human embryonic stem cells". Cell. 122 (6): 947-956. doi:10.1016/j.cell.2005.08.020. PMC 3006442. PMID 16153702.^ Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, et al. (The International Stem Cell Initiative) (July 2007). "Characterization of human embryonic stem cell strains by the International Stem Cell Initiative". Nature Biotechnology. 25 (7): 803-816. doi:10.1038/nbt1318. PMID 17572666. S2CID 13780999.^ Mahla RS (2016). "Stem Cells Applications in Regenerative Medicine and Disease Therapeutics". International Journal of Cell Biology. 2016 (7): 1-24. doi:10.1155/2016/6940283. PMC 4969512. PMID 27516776.^ Winslow R, Mundy A (23 January 2009). "First Embryonic Stem-Cell Trial Gets Approval from the FDA". The Wall Street Journal.^ "Embryonic Stem Cell Therapy In danger? Geron Ends Clinical Trial". ScienceDebate.com. Archived from the unique on 2014-08-22. Retrieved 2011-12-11.^ Wu DC, Boyd AS, Wood KJ (May 2007). "Embryonic stem cell transplantation: potential applicability in cell substitute therapy and regenerative medicine". Frontiers in Bioscience. 12 (8-12): 4525-35. doi:10.2741/2407. PMID 17485394. S2CID 6355307.^ a b Zomer HD, Vidane AS, Gonçalves NN, Ambrósio CE (2015-09-28). "Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives". Stem Cells and Cloning: Advances and Applications. 8: 125-134. doi:10.2147/SCCAA.S88036. PMC 4592031. PMID 26451119.^ Caplan AI (September 1991). "Mesenchymal stem cells". Journal of Orthopaedic Research. 9 (5): 641-650. doi:10.1002/jor.1100090504. PMID 1870029. S2CID 22606668.^ Krasilnikova, O. A.; Baranovskii, D. S.; Lyundup, A. V.; Shegay, P. V.; Kaprin, A. D.; Klabukov, I. D. (2022-04-27). "Stem and Somatic Cell Monotherapy for the Treatment of Diabetic Foot Ulcers: Review of Clinical Studies and Mechanisms of Action". Stem Cell Reviews and Reports. 18 (6): 1974-1985. doi:10.1007/s12015-022-10379-z. ISSN 2629-3277. PMID 35476187. S2CID 248402820.^ a b c d e f Koledova Z, Krämer A, Kafkova LR, Divoky V (November 2010). "Cell-cycle regulation in embryonic stem cells: centrosomal choices on self-renewal". Stem Cells and Development. 19 (11): 1663-1678. doi:10.1089/scd.2010.0136. PMID 20594031.^ a b c d Barta T, Dolezalova D, Holubcova Z, Hampl A (March 2013). "Cell cycle regulation in human embryonic stem cells: hyperlinks to adaptation to cell tradition". Experimental Biology and Medicine. 238 (3): 271-275. doi:10.1177/1535370213480711. PMID 23598972. S2CID 2028793.^ a b c d e f g Zaveri L, Dhawan J (2018). "Cycling to satisfy Fate: Connecting Pluripotency to the Cell Cycle". Frontiers in Cell and Developmental Biology. 6: 57. doi:10.3389/fcell.2018.00057. PMC 6020794. PMID 29974052.^ Koledova Z, Kafkova LR, Calabkova L, Krystof V, Dolezel P, Divoky V (February 2010). "Cdk2 inhibition prolongs G1 part development in mouse embryonic stem cells". Stem Cells and Development. 19 (2): 181-194. doi:10.1089/scd.2009.0065. PMID 19737069.^ Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, van Wijnen AJ, Stein GS (December 2006). "Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase". Journal of Cellular Physiology. 209 (3): 883-893. doi:10.1002/jcp.20776. PMID 16972248. S2CID 24908771.^ Ariff Bongso; Eng Hin Lee, eds. (2005). "Stem cells: their definition, classification and sources". Stem Cells: From Benchtop to Bedside. World Scientific. p. 5. ISBN 978-981-256-126-8. OCLC 443407924.^ Moore, Keith L.; Persaud, T. V. N.; Torchia, Mark G. (2013). Before We're Born: Essentials of Embryology and Birth Defects. Saunders/Elsevier. ISBN 978-1-4377-2001-3.[web page needed]^ "What is a stem cell". anthonynolan.org. Anthony Nolan. Retrieved 17 February 2022.^ "Bone marrow (stem cell) donation: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2021-10-17.^ Coughlin RP, Oldweiler A, Mickelson DT, Moorman CT (October 2017). "Adipose-Derived Stem Cell Transplant Technique for Degenerative Joint Disease". Arthroscopy Techniques. 6 (5): e1761-e1766. doi:10.1016/j.eats.2017.06.048. PMC 5795060. PMID 29399463.^ "autologous stem cell transplant". www.most cancers.gov. 2011-02-02. Retrieved 2022-06-26.^ Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M (May 2007). "A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in grownup bone marrow and other tissues". Leukemia. 21 (5): 860-867. doi:10.1038/sj.leu.2404630. PMID 17344915. S2CID 21433689.^ Narasipura SD, Wojciechowski JC, Charles N, Liesveld JL, King MR (January 2008). "P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow". Clinical Chemistry. 54 (1): 77-85. doi:10.1373/clinchem.2007.089896. PMID 18024531.^ Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I (October 2006). "Improved liver operate in patients with liver cirrhosis after autologous bone marrow cell infusion therapy". Stem Cells. 24 (10): 2292-2298. doi:10.1634/stemcells.2005-0542. PMID 16778155. S2CID 5649484.^ Subrammaniyan R, Amalorpavanathan J, Shankar R, Rajkumar M, Baskar S, Manjunath SR, Senthilkumar R, Murugan P, Srinivasan VR, Abraham S (September 2011). "Application of autologous bone marrow mononuclear cells in six patients with superior chronic crucial limb ischemia as a result of diabetes: our experience". Cytotherapy. Thirteen (8): 993-999. doi:10.3109/14653249.2011.579961. PMID 21671823. S2CID 27251276.^ Madhusankar N (2007). "Use of Bone Marrow derived Stem Cells in Patients with Cardiovascular Disorders". Journal of Stem Cells and Regenerative Medicine. Three (1): 28-29. PMC 3908115. PMID 24693021.^ Dedeepiya VD, Rao YY, Jayakrishnan GA, Parthiban JK, Baskar S, Manjunath SR, Senthilkumar R, Abraham SJ (2012). "Index of CD34+ Cells and Mononuclear Cells within the Bone Marrow of Spinal Cord Injury Patients of various Age Groups: A Comparative Analysis". Bone Marrow Research. 2012: 1-8. doi:10.1155/2012/787414. PMC 3398573. PMID 22830032.^ Gardner RL (March 2002). "Stem cells: potency, plasticity and public notion". Journal of Anatomy. 200 (Pt 3): 277-282. doi:10.1046/j.1469-7580.2002.00029.x. PMC 1570679. PMID 12033732.^ Behrens A, van Deursen JM, Rudolph KL, Schumacher B (March 2014). "Impact of genomic harm and ageing on stem cell perform". Nature Cell Biology. Sixteen (3): 201-207. doi:10.1038/ncb2928. PMC 4214082. PMID 24576896.^ Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC (November 2006). "Review: ex vivo engineering of dwelling tissues with grownup stem cells". Tissue Engineering. 12 (11): 3007-3019. CiteSeerX 10.1.1.328.2873. doi:10.1089/ten.2006.12.3007. PMID 17518617.^ Gimble JM, Katz AJ, Bunnell BA (May 2007). "Adipose-derived stem cells for regenerative medicine". Circulation Research. A hundred (9): 1249-1260. doi:10.1161/01.RES.0000265074.83288.09. PMC 5679280. PMID 17495232.^ Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, Shigemoto T, Nabeshima Y, Nakahata T, Nabeshima Y, Fujiyoshi Y, Dezawa M (May 2010). "Unique multipotent cells in grownup human mesenchymal cell populations". Proceedings of the National Academy of Sciences of the United States of America. 107 (19): 8639-8643. Bibcode:2010PNAS..107.8639K. doi:10.1073/pnas.0911647107. PMC 2889306. PMID 20421459.^ "Bone Marrow Transplant". ucsfchildrenshospital.org.^ Kane, Ed (2008-05-01). "Stem-cell therapy reveals promise for horse comfortable-tissue harm, disease". DVM Newsmagazine. Archived from the original on 2008-12-11. Retrieved 2008-06-12.^ "Stem Cell FAQ". US Department of Health and Human Services. 2004-07-14. Archived from the unique on 2009-01-09.^ Oliveira PH, da Silva CL, Cabral JM (2014). "Genomic Instability in Human Stem Cells: Current Status and Future Challenges". Stem Cells. 32 (11): 2824-2832. doi:10.1002/stem.1796. PMID 25078438. S2CID 41335566.^ a b Zhang L, Mack R, Breslin P, Zhang J. Molecular and cellular mechanisms of aging in hematopoietic stem cells and their niches. J Hematol Oncol. 2020 Nov 23;13(1):157. doi: 10.1186/s13045-020-00994-z. PMID 33228751; PMCID: PMC7686726^ Montazersaheb S, Ehsani A, Fathi E, Farahzadi R. Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect. Oxid Med Cell Longev. 2022 Apr 1;2022:2713483. doi: 10.1155/2022/2713483. PMID 35401928; PMCID: PMC8993567^ De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A (January 2007). "Isolation of amniotic stem cell lines with potential for therapy". Nature Biotechnology. 25 (1): 100-106. doi:10.1038/nbt1274. PMID 17206138. S2CID 6676167.^ "Vatican newspaper calls new stem cell source 'future of medicine'". Catholic News Agency. Three February 2010.^ "European Biotech Company Biocell Center Opens First U.S. Facility for Preservation of Amniotic Stem Cells in Medford, Massachusetts". Reuters. 2009-10-22. Archived from the original on 2009-10-30. Retrieved 2010-03-14.^ "Europe's Biocell Center opens Medford office - Daily Business Update". The Boston Globe. 2009-10-22. Retrieved 2010-03-14.^ "The Ticker". BostonHerald.com. 2009-10-22. Retrieved 2010-03-14.^ "Biocell Center opens amniotic stem cell bank in Medford". Mass High Tech Business News. 2009-10-23. Archived from the unique on 2012-10-14. Retrieved 2012-08-26.^ "World's First Amniotic Stem Cell Bank Opens In Medford". wbur.org. 22 October 2009. Retrieved 2010-03-14.^ "Biocell Center Corporation Partners with New England's Largest Community-Based Hospital Network to supply a novel..." (Press launch). Medford, Mass.: Prnewswire.com. Retrieved 2010-03-14.^ a b c "Making human embryonic stem cells". The Economist. 2007-11-22.^ Brand M, Palca J, Cohen A (2007-11-20). "Skin Cells Can Become Embryonic Stem Cells". National Public Radio.^ "Breakthrough Set to seriously change Stem Cell Debate". News Hour with Jim Lehrer. 2007-11-20. Archived from the unique on 2014-01-22. Retrieved 2017-09-15.^ a b c d e Kimbrel EA, Lanza R (December 2016). "Pluripotent stem cells: the final 10 years". Regenerative Medicine. 11 (8): 831-847. doi:10.2217/rme-2016-0117. PMID 27908220.^ a b c Takahashi K, Yamanaka S (August 2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined components". Cell. 126 (4): 663-676. doi:10.1016/j.cell.2006.07.024. hdl:2433/159777. PMID 16904174. S2CID 1565219.^ Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by outlined factors". Cell. 131 (5): 861-872. doi:10.1016/j.cell.2007.11.019. hdl:2433/49782. PMID 18035408. S2CID 8531539.^ Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (December 2007). "Induced pluripotent stem cell strains derived from human somatic cells". Science. 318 (5858): 1917-1920. Bibcode:2007Sci...318.1917Y. doi:10.1126/science.1151526. PMID 18029452. S2CID 86129154.^ "His inspiration comes from the research by Prof Shinya Yamanaka at Kyoto University, which suggests a technique to create human embryo stem cells with out the necessity for human eggs, that are in extremely quick supply, and without the necessity to create and destroy human cloned embryos, which is bitterly opposed by the pro life movement." Highfield R (2007-11-16). "Dolly creator Prof Ian Wilmut shuns cloning". The Telegraph. London. Archived from the original on 2009-07-30.^ Maldonado M, Luu RJ, Ico G, Ospina A, Myung D, Shih HP, Nam J (September 2017). "Lineage- and developmental stage-specific mechanomodulation of induced pluripotent stem cell differentiation". Stem Cell Research & Therapy. 8 (1): 216. doi:10.1186/s13287-017-0667-2. PMC 5622562. PMID 28962663.^ a b Robinton, DA; Daley, GQ (January 2012). "The promise of induced pluripotent stem cells in research and therapy". Nature. 481 (7381): 295-305. Bibcode:2012Natur.481..295R. doi:10.1038/nature10761. PMC 3652331. PMID 22258608.^ Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, Jaenisch R (July 2010). "Reprogramming of human peripheral blood cells to induced pluripotent stem cells". Cell Stem Cell. 7 (1): 20-24. doi:10.1016/j.stem.2010.06.002. PMC 2917234. PMID 20621045. - Lay abstract in: "Frozen blood a source of stem cells, study finds". NewsDaily. Reuters. 2010-07-01. Archived from the unique on 2010-07-03.

^ Chen X, Hartman A, Guo S (2015-09-01). "Choosing Cell Fate Through a Dynamic Cell Cycle". Current Stem Cell Reports. 1 (3): 129-138. doi:10.1007/s40778-015-0018-0. PMC 5487535. PMID 28725536.^ Hindley C, Philpott A (April 2013). "The cell cycle and pluripotency". The Biochemical Journal. 451 (2): 135-143. doi:10.1042/BJ20121627. PMC 3631102. PMID 23535166.^ Fox, D.T.; Morris, L.X.; Nystul, T.; Spradling, A.C. (2008). "Lineage evaluation of stem cells". StemBook. doi:10.3824/stembook.1.33.1. PMID 20614627.^ Beckmann, Julia; Scheitza, Sebastian; Wernet, Peter; Fischer, Johannes C.; Giebel, Bernd (15 June 2007). "Asymmetric cell division inside the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins". Blood. 109 (12): 5494-5501. doi:10.1182/blood-2006-11-055921. PMID 17332245.^ Xie, Ting; Spradling, Allan C (July 1998). "decapentaplegic Is essential for the Maintenance and Division of Germline Stem Cells within the Drosophila Ovary". Cell. 94 (2): 251-260. doi:10.1016/s0092-8674(00)81424-5. PMID 9695953. S2CID 11347213.^ Song, X.; Zhu, CH; Doan, C; Xie, T (7 June 2002). "Germline Stem Cells Anchored by Adherens Junctions in the Drosophila Ovary Niches". Science. 296 (5574): 1855-1857. Bibcode:2002Sci...296.1855S. doi:10.1126/science.1069871. PMID 12052957. S2CID 25830121.^ "Executive Order: Removing barriers to accountable scientific analysis involving human stem cells". whitehouse.gov. 9 March 2009 - via National Archives.^ "National Institutes of Health Guidelines on Human Stem Cell Research". Retrieved 24 April 2014.^ "NIH Human Embryonic Stem Cell Registry". Retrieved 1 March 2017.^ "NIH Human Embryonic Stem Cell Registry". Retrieved 10 February 2022.^ a b Ian Murnaghan for Explore Stem Cells. Updated: 16 December 2013 Why Perform a Stem Cell Transplant?^ Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation In Nat